I stepped down as I won't be around. IMO dead money for many months to come based on the timeline extension on scaffold and much longer followup study before commercialization. Furthermore, the hydrogel timeline schedule is under review at this moment according to the latest PR from the new CEO, and that will be another shoe that drops when hydrogel is pushed back from original September schedule.
I am also afraid of legal problems related to ex-CEO - could be sued for false statements on Investor Presentation or a few other things. Whether any suit progresses doesn't matter, but it will hurt the stock nonetheless with respect to investor sentiment.
If you decide to hold, good luck to you, but at this point there could be another hit piece any day on the monkey trials having been falsified, or a PR which pushes back all of their other product timelines by months to years, any of which will shave another $0.50 or 33 percent from the share price.
Good luck to folks who are long, short, or on the sidelines.